Connection

Nivedita Gupta to Humans

Back to Details
This is a "connection" page, showing publications Nivedita Gupta has written about Humans.
Nivedita Gupta
Connection Strength
0.106
Humans
  1. Pooled testing for COVID-19 diagnosis by real-time RT-PCR: A multi-site comparative evaluation of 5- & 10-sample pooling. Indian J Med Res. 2020 Jul & Aug; 152(1 & 2):88-94.
    View in: PubMed
    Score: 0.007
  2. Authors' response. Indian J Med Res. 2020 05; 151(5):496.
    View in: PubMed
    Score: 0.007
  3. Laboratory preparedness for SARS-CoV-2 testing in India: Harnessing a network of Virus Research & Diagnostic Laboratories. Indian J Med Res. 2020 Feb & Mar; 151(2 & 3):216-225.
    View in: PubMed
    Score: 0.007
  4. Biorisk assessment for infrastructure & biosafety requirements for the laboratories providing coronavirus SARS-CoV-2/(COVID-19) diagnosis. Indian J Med Res. 2020 Feb & Mar; 151(2 & 3):172-176.
    View in: PubMed
    Score: 0.007
  5. Strategic planning to augment the testing capacity for COVID-19 in India. Indian J Med Res. 2020 Feb & Mar; 151(2 & 3):210-215.
    View in: PubMed
    Score: 0.007
  6. Severe acute respiratory illness surveillance for coronavirus disease 2019, India, 2020. Indian J Med Res. 2020 Feb & Mar; 151(2 & 3):236-240.
    View in: PubMed
    Score: 0.007
  7. Acute Encephalitis Syndrome in Eastern Uttar Pradesh, India: Changing Etiological Understanding. J Med Entomol. 2018 05 04; 55(3):523-526.
    View in: PubMed
    Score: 0.006
  8. Neutralization of VUI B.1.1.28 P2 variant with sera of COVID-19 recovered cases and recipients of Covaxin an inactivated COVID-19 vaccine. J Travel Med. 2021 10 11; 28(7).
    View in: PubMed
    Score: 0.002
  9. Neutralization of Beta and Delta variant with sera of COVID-19 recovered cases and vaccinees of inactivated COVID-19 vaccine BBV152/Covaxin. J Travel Med. 2021 10 11; 28(7).
    View in: PubMed
    Score: 0.002
  10. Neutralization of Delta variant with sera of Covishield™ vaccinees and COVID-19-recovered vaccinated individuals. J Travel Med. 2021 10 11; 28(7).
    View in: PubMed
    Score: 0.002
  11. Inactivated COVID-19 vaccine BBV152/COVAXIN effectively neutralizes recently emerged B.1.1.7 variant of SARS-CoV-2. J Travel Med. 2021 Jun 01; 28(4).
    View in: PubMed
    Score: 0.002
  12. An Epidemiological Analysis of SARS-CoV-2 Genomic Sequences from Different Regions of India. Viruses. 2021 05 17; 13(5).
    View in: PubMed
    Score: 0.002
  13. SARS-CoV-2 re-infection: development of an epidemiological definition from India. Epidemiol Infect. 2021 03 26; 149:e82.
    View in: PubMed
    Score: 0.002
  14. Imported SARS-CoV-2 V501Y.V2 variant (B.1.351) detected in travelers from South Africa and Tanzania to India. Travel Med Infect Dis. 2021 May-Jun; 41:102023.
    View in: PubMed
    Score: 0.002
  15. Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: interim results from a double-blind, randomised, multicentre, phase 2 trial, and 3-month follow-up of a double-blind, randomised phase 1 trial. Lancet Infect Dis. 2021 07; 21(7):950-961.
    View in: PubMed
    Score: 0.002
  16. India's crusade against COVID-19. Nat Immunol. 2021 03; 22(3):258-259.
    View in: PubMed
    Score: 0.002
  17. Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial. Lancet Infect Dis. 2021 05; 21(5):637-646.
    View in: PubMed
    Score: 0.002
  18. Performance evaluation of Truenat™ Beta CoV & Truenat™ SARS-CoV-2 point-of-care assays for coronavirus disease 2019. Indian J Med Res. 2021 Jan & Feb; 153(1 & 2):144-150.
    View in: PubMed
    Score: 0.002
  19. SARS-CoV-2 detection in sewage samples: Standardization of method & preliminary observations. Indian J Med Res. 2021 Jan & Feb; 153(1 & 2):159-165.
    View in: PubMed
    Score: 0.002
  20. Feasibility, efficiency & effectiveness of pooled sample testing strategy (pooled NAAT) for molecular testing of COVID-19. Indian J Med Res. 2021 Jan & Feb; 153(1 & 2):227-232.
    View in: PubMed
    Score: 0.002
  21. A cluster of SARS-CoV-2 infection among Italian tourists visiting India, March 2020. Indian J Med Res. 2020 May; 151(5):438-443.
    View in: PubMed
    Score: 0.002
  22. Development of indigenous IgG ELISA for the detection of anti-SARS-CoV-2 IgG. Indian J Med Res. 2020 May; 151(5):444-449.
    View in: PubMed
    Score: 0.002
  23. The 2019 novel coronavirus disease (COVID-19) pandemic: A review of the current evidence. Indian J Med Res. 2020 Feb & Mar; 151(2 & 3):147-159.
    View in: PubMed
    Score: 0.002
  24. Lopinavir/ritonavir combination therapy amongst symptomatic coronavirus disease 2019 patients in India: Protocol for restricted public health emergency use. Indian J Med Res. 2020 Feb & Mar; 151(2 & 3):184-189.
    View in: PubMed
    Score: 0.002
  25. First isolation of SARS-CoV-2 from clinical samples in India. Indian J Med Res. 2020 Feb & Mar; 151(2 & 3):244-250.
    View in: PubMed
    Score: 0.002
  26. Genomic analysis of SARS-CoV-2 strains among Indians returning from Italy, Iran & China, & Italian tourists in India. Indian J Med Res. 2020 Feb & Mar; 151(2 & 3):255-260.
    View in: PubMed
    Score: 0.002
  27. Spatial Association Between a Nipah Virus Outbreak in India and Nipah Virus Infection in Pteropus Bats. Clin Infect Dis. 2019 07 02; 69(2):378-379.
    View in: PubMed
    Score: 0.002
  28. Burden of dengue infection in India, 2017: a cross-sectional population based serosurvey. Lancet Glob Health. 2019 08; 7(8):e1065-e1073.
    View in: PubMed
    Score: 0.002
  29. Comparison of two commercial ELISA kits for detection of rubella specific IgM in suspected congenital rubella syndrome cases and rubella IgG antibodies in a serosurvey of pregnant women. Diagn Microbiol Infect Dis. 2019 Jul; 94(3):243-247.
    View in: PubMed
    Score: 0.002
  30. Epidemiology of dengue fever in India, based on laboratory surveillance data, 2014-2017. Int J Infect Dis. 2019 Jul; 84S:S10-S14.
    View in: PubMed
    Score: 0.002
  31. Risk Factors for Acquiring Scrub Typhus among Children in Deoria and Gorakhpur Districts, Uttar Pradesh, India, 2017. Emerg Infect Dis. 2018 12; 24(12):2364-2367.
    View in: PubMed
    Score: 0.002
  32. Sero-prevalence of rubella among pregnant women in India, 2017. Vaccine. 2018 12 18; 36(52):7909-7912.
    View in: PubMed
    Score: 0.002
  33. Acute Encephalitis Syndrome in Gorakhpur, Uttar Pradesh, 2016: Clinical and Laboratory Findings. Pediatr Infect Dis J. 2018 11; 37(11):1101-1106.
    View in: PubMed
    Score: 0.002
  34. Epidemiology of Hepatitis A and Hepatitis E Based on Laboratory Surveillance Data-India, 2014-2017. Am J Trop Med Hyg. 2018 10; 99(4):1058-1061.
    View in: PubMed
    Score: 0.002
  35. Sentinel Surveillance for Congenital Rubella Syndrome - India, 2016-2017. MMWR Morb Mortal Wkly Rep. 2018 Sep 14; 67(36):1012-1016.
    View in: PubMed
    Score: 0.002
  36. Burden of bacterial meningitis in India: Preliminary data from a hospital based sentinel surveillance network. PLoS One. 2018; 13(5):e0197198.
    View in: PubMed
    Score: 0.002
  37. First laboratory confirmation on the existence of Zika virus disease in India. J Infect. 2018 03; 76(3):314-317.
    View in: PubMed
    Score: 0.001
  38. Scrub Typhus as an Etiology of Acute Febrile Illness in Gorakhpur, Uttar Pradesh, India, 2016. Am J Trop Med Hyg. 2017 Nov; 97(5):1313-1315.
    View in: PubMed
    Score: 0.001
  39. Scrub Typhus as a Cause of Acute Encephalitis Syndrome, Gorakhpur, Uttar Pradesh, India. Emerg Infect Dis. 2017 08; 23(8):1414-1416.
    View in: PubMed
    Score: 0.001
  40. The syndrome of acute encephalitis in children in India: Need for new thinking. Indian J Med Res. 2017 08; 146(2):158-161.
    View in: PubMed
    Score: 0.001
  41. Mapping dengue cases through a national network of laboratories, 2014-2015. Indian J Med Res. 2016 Dec; 144(6):938-941.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.